cisplatin,pembrolizumab,interferon alfa-2b
biogen,merck
['mibc', 'pembro', ' cis ', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'interferon alfa-2b', 'biomarker', 'bladder', 'marker ']
can we change the treatment paradigm and outcomes in nmibc? #gu23 #medtwitter #bladdercancer 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni